MedPath

Randomized clinical trial: how a plant called Eclipta prostrata (commonly known as false daisy) can help people with Obesity

Phase 2
Conditions
utrition disorders
overnutrition
obesity
Registration Number
RBR-5wy4vhx
Lead Sponsor
Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Adults of both genders; aged 18 to 59; with grade I obesity; monitored in primary healthcare unities

Exclusion Criteria

Participants with comorbidities characterized by low-grade chronic inflammation, except for those associated with obesity and metabolic syndrome; history of chronic use of corticosteroids, immunosuppressants, or nonsteroidal anti-inflammatory drugs; health conditions that may interfere with the parameters measured by bioelectrical impedance analysis, such as edema, chronic kidney disease, end-stage organ failure, or amputated limbs; implanted cardiac devices; chronic diarrhea; ethical restrictions that prevent proper consent for study participation; women who are pregnant or breastfeeding

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath